findmyKOL

Monique Starks, MD

Basic profile

Cardiovascular Disease

ORCIDNone on fileNPI
RegionDurham, NC · SoutheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNot yet indexedOnline presenceNot yet checkedPaymentsNone reportedNIH funding2020–2024Why? →

Monique Starks is a Cardiology physician. ClinicalTrials.gov lists 1 registered study matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)

Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials
1NIH grants · 2020–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

40 Duke Medicine Cir
Durham, NC 277104000

Telephone

919-684-8111

Registry record last updated 9 Aug 2017.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    75.9%
    Beta blocker19.5%
    Carvedilol58%Metoprolol Succinate42%
    Part D21 patients
    Statin13.1%
    Atorvastatin Calcium51%Rosuvastatin Calcium49%
    Part D17 patients

    + 10 more classes in this area

  • Metabolism & gastrointestinal

    12.3%
    Proton pump inhibitor4%
    Omeprazole52%Pantoprazole Sodium48%
    Part D<11 patients
    Potassium supplement3.4%
    Potassium Chloride100%
    Part D<11 patients

    + 2 more classes in this area

  • Blood & clotting

    11.8%
    Factor Xa inhibitor8.8%
    Eliquis100%
    Part D12 patients
    P2Y12 inhibitor3%
    Clopidogrel100%
    Part D<11 patients
Where care is delivered (Part B)5.2% facility · 94.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20202024 per NIH RePORTER. The latest:

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”